In the conclusion of this three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.
Jason Bryant
Advertisement
Jason Bryant is vice-president, Product Management for AI & Data at ArisGlobal, based in London. A data science actuary, he has built his career in fintech and health-tech, and specializes in AI-powered, data-driven, yet human-centric product innovation. He previously led an AstraZeneca digital incubator and today remains on the board of a health charity, Scleroderma & Raynaud's UK (SRUK), which is dedicated to improving the lives of people affected by those conditions in the UK.
Articles by Jason Bryant
In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.
In a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
